This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sauer, L. A. Articles by Dauchy, R. T. Search for Related Content PubMed Articles by Sauer, L. A. Articles by Dauchy, R. T.

Stimulation of Tumor Growth in Adult Rats in Vivo during Acute Streptozotocin-induced Diabetes¹

Laboratory for Cancer Research, The Bassett Institute for Medical Research, The Mary Imogene Bassett Hospital, Cooperstown, New York 13326

The effects of acute diabetes mellitus on the growth of Morris hepatoma 7288CTC and Jensen sarcoma were studied in fed, young (less than 200 g), and adult (greater than 250 g) rats. Animals were matched for tumor size and growth; the rates of tumor growth were the same in fed, young and adult nondiabetic rats. Diabetes was induced by the i.v. injection of streptozotocin (65 mg/kg total body weight) into tumor-bearing rats and changes in arterial blood nutrient concentrations were compared to changes in the rates of tumor growth and DNA synthesis. In young rats acute diabetes did not increase the blood concentrations of the fat store-derived nutrients and did not increase the rate of tumor growth. In adult rats, however, acute diabetes raised the arterial blood free fatty acid, glycerol, triglyceride, and ketone body concentrations to high levels and increased the rate of tumor growth about three times over that observed in untreated rats. Progress curves for the mobilization of host fat stores and for incorporation of [methyl-³H]thymidine into tumor DNA during the onset of diabetes showed that these activities were closely correlated in adult rats. Both processes began to increase 2 to 4 h after streptozotocin treatment, reached an initial peak at 12 to 16 h, decreased to a low point at 18 to 20 h, and then increased again to the new steady state after 23 to 24 h. The results indicate that the rate of tumor growth in rats in vivo is limited by the availability of a substance(s) present in the hyperlipemic blood of adult diabetic rats. The tight relationship between host lipolysis and tumor growth suggests that the substance(s) is derived from host fat stores.

¹ This investigation was supported by USPHS Grant CA 27809, awarded by the National Cancer Institute, Department of Health and Human Services, and by the Stephen Carlton Clark Research Fund of The Mary Imogene Bassett Hospital.

² To whom requests for reprints should be addressed.

Received 11/12/86. Accepted 12/29/86.

This article has been cited by other articles:

				L. A. Sauer, R. T. Dauchy, and D. E. Blask Mechanism for the Antitumor and Anticachectic Effects of n-3 Fatty Acids Cancer Res., September 1, 2000; 60(18): 5289 - 5295. [Abstract] [Full Text]

				L. A. Sauer, R. T. Dauchy, D. E. Blask, B. J. Armstrong, and S. Scalici 13-Hydroxyoctadecadienoic Acid Is the Mitogenic Signal for Linoleic Acid-dependent Growth in Rat Hepatoma 7288CTC in Vivo Cancer Res., September 1, 1999; 59(18): 4688 - 4692. [Abstract] [Full Text] [PDF]

				D. E. Blask, L. A. Sauer, R. T. Dauchy, E. W. Holowachuk, M. S. Ruhoff, and H. S. Kopff Melatonin Inhibition of Cancer Growth in Vivo Involves Suppression of Tumor Fatty Acid Metabolism via Melatonin Receptor-mediated Signal Transduction Events Cancer Res., September 1, 1999; 59(18): 4693 - 4701. [Abstract] [Full Text] [PDF]